Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterovirus A71 (EV-A71) is a highly transmissible neurotropic enterovirus responsible for hand-foot-and-mouth disease epidemics globally—especially among young children—and can cause rare but serious neurological complications. Its structure consists of a small RNA genome encoding both structural capsid proteins critical for host cell attachment/invasion via specific receptors like SCARB2. While effective vaccines exist only regionally so far—and no targeted antivirals are available—ongoing research continues toward broader prevention strategies worldwide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus A71 (EV-A71).